e.g. Tata motors, Reliance MF, 500570

Bharat Immunological & Biologicals Corporation Ltd. - Research Center

524663 BIBCL Group (B) BSE data
 
Back to Company Page
Statement:

Balance sheet

(Rs crore)
Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19 Mar ' 18
Sources of funds
Owner's fund
Equity share capital 43.18 43.18 43.18 43.18 43.18
Share application money - - - - -
Preference share capital - - - - -
Reserves & surplus 62.17 -9.14 -22.71 -12.50 -5.68
Loan funds
Secured loans 77.89 27.29 3.04 - -
Unsecured loans - - - 32.22 -
Total 183.24 61.33 23.51 62.90 37.50
Uses of funds
Fixed assets
Gross block 125.72 45.66 5.97 5.97 5.94
Less : revaluation reserve - - - - -
Less : accumulated depreciation 41.64 41.43 1.50 1.27 0.99
Net block 84.08 4.23 4.47 4.70 4.95
Capital work-in-progress 31.90 31.90 0.22 0.22 0.22
Investments - - - - -
Net current assets
Current assets, loans & advances 96.75 67.86 122.15 120.04 48.23
Less : current liabilities & provisions 29.49 42.65 103.32 62.06 15.91
Total net current assets 67.26 25.21 18.83 57.98 32.32
Miscellaneous expenses not written - - - - -
Total 183.24 61.33 23.51 62.90 37.50
Notes:
Book value of unquoted investments - - - - -
Market value of quoted investments - - - - -
Contingent liabilities 0.04 0.04 0.04 0.66 3.96
Number of equity sharesoutstanding (Lacs) 431.80 431.80 431.80 431.80 431.80
Close
Add Bharat Immunological & Biologicals Corporation Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Bharat Immunological & Biologicals Corporation Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback